From the National Blood Clot Alliance:
March is Blood Clot Awareness Month (BCAM), a time dedicated to spreading the word about blood clots and their potentially fatal complication, pulmonary embolism.
Throughout the month, NBCA’s “anyBODY Can Get a Blood Clot” campaign will raise awareness about how blood clots can happen to anyone, regardless of age, race, or gender.
Why is it important to raise blood clot awareness?
- Less than 6% of Americans know what blood clots are and how to prevent them, yet they affect as many as 900,000 Americans every year.
- Every six minutes in the U.S., someone dies of a blood clot.
- The overall incidence of venous blood clots is 30-60% higher in Black patients compared to white patients.
- 274 people die every day in the U.S. from blood clots.
- A blood clot in the lung is one of the most common causes of pregnancy-related death in the U.S.
- Blood clots are the second leading cause of death in cancer patients, aside from cancer itself.
More information: https://www.stoptheclot.org/blood-clot-awareness-month-2023

Dr. George Davis (PharmD) is Antithrombosis Stewardship Program Coordinator at UK HealthCare Pharmacy Services and Adjunct Professor with University of Kentucky College of Pharmacy. He completed pharmacy residency and research fellowship training at the University of Kentucky and has been a clinical pharmacist at UK HealthCare for over 25 years with practice, teaching, research, and scholarly activity focused in clinical pharmacokinetics and antithrombosis pharmacotherapeutics. In his current position, he is Antithrombosis Stewardship Program Coordinator including lead pharmacist of the UK HealthCare Anticoagulation Stewardship Program that includes involvement in a multidisciplinary antithrombosis consult service, quality assurance/safety, and formulary management of antithrombotics. Most recently, he is co-lead of the multidisciplinary Pulmonary Embolism Response Team (PERT) at UK HealthCare and actively involved in the National PERT Consortium including serving as a member of the PERT Consortium Board of Directors and Education, Protocol Development, and Research committees.